Sydney Children's Hospital, Randwick
The Sydney Children’s Hospital, Randwick, is a leading paediatric research institution, actively involved in over 250 active clinical trials across a wide range of therapeutic areas.
Sydney Children’s Hospital, Randwick (SCH) is a leading paediatric research institution within the Sydney Children’s Hospitals Network (SCHN), who are actively involved in over 250 active clinical trials across a wide range of therapeutic areas. These include oncology (glioma, neuroblastoma, leukaemia), immunology, rare genetic disorders, infectious diseases, and advanced therapeutics such as gene therapy. SCH are a global leader and has been the first global site for several paediatric trials, including viral vector-based gene therapy for Duchenne muscular dystrophy.
There are over 100 experienced principal investigators working across all clinical areas in clinical trials at SCHN.
Hospital departments supporting clinical trials
Clinical trials at SCH are supported by a multidisciplinary network of departments including:
- Dermatology
- Gastroenterology
- Respiratory
- Neurology
- Infectious Diseases
- Oncology and Haematology
- Endocrinology
- Rehabilitation
- Intensive Care
- Behavioural Sciences
- Drug and Alcohol
These departments collaborate closely with the Kids Research arm of SCHN, which provides infrastructure and governance for research activities.
There are dedicated paediatric facilities that support clinical trial conduct including
- Cardiac Services – Electrocardiogram (ECG), Echocardiogram (ECHO)
- Spirometry
- Pharmacy
Facility equipment
SCH hosts state-of-the-art research and clinical facilities. The Clinical Research Centre (CRC) support a broad range of clinical trials activity onsite as well as clinical trials capabilities embedded within clinical services.
Equipment and services within the SCH facility includes;
- Access to laboratory facilities for collection and processing of research samples
- Ambient, refrigerated, -20°C & -80°C Investigational Product (IP) storage
- Digital temperature monitoring & excursion alerts for all IP and specimen storage
- Ambient, refrigerated, -20°C & -80°C and incubated specimen storage
- Refrigerated and ambient centrifuges
- Vital signs equipment
- ECG machine
- Pharmacy drug safe
- Access to clinic spaces
- Sponsor delegate monitoring space
- Building alarms & lockable rooms
- Secure storage of IP & trial documents
- Offsite archiving at secure storage facility
Ethics and Governance information and safety reporting
All research at SCH is governed by the SCHN Human Research Ethics Committee (HREC), certified by the National Health and Medical Research Council (NHMRC) and operating under the National Mutual Acceptance scheme. The HREC reviews all levels of risk (negligible, low, and greater than low) and works in alignment with the National Statement on Ethical Conduct in Human Research and ICH-GCP guidelines. Governance oversight is provided by the SCHN Research Governance Office, ensuring compliance with NSW Health and national standards.
Safety monitoring and reporting are conducted in accordance with NHMRC guidelines and ICH-GCP standards. SCH maintains robust systems for adverse event reporting, including independent data safety monitoring boards for high-risk trials. The SCHN HREC oversees post-approval safety and ethical compliance
Consumer involvement
Consumer and community involvement is a core principle at SCH. The hospital engages families and carers in research design and implementation, particularly in areas such as paediatric intensive care and transition care for adolescents. The Kids Research team actively seeks and incorporates consumer feedback into trial protocols and dissemination strategies. SCHN have implemented a consumer feedback survey designed specifically for participants of clinical trials.
Electronic systems
The following electronic systems are used at SCHN to facilitate clinical trials management;
- Clinical Trials Management System (CTMS) - all clinical trials activated at SCHN since 1 April 2024 are mandated to use CTMS. The CTMS is utilised for study tracking, site feasibility, and resource allocation.
- Electronic Investigator Site File (eISF) - all clinical trials managed at SCHN have access to an eISF for document storage and management of the clinical trials.
- REDCap is used for investigator-led studies and secure data collection.
- Electronic Data Capture (EDC) - staff working in clinical trials are trained and experienced in the use of several EDCs to facilitate data entry for clinical trials.
- Secure Email and Document Management - Microsoft Outlook and SharePoint are utlised for communication and controlled document storage.
Standard Operating Procedures (SOPs) and Policy
SCHN utlises a suite of SOPs covering all aspects of clinical trials start up, management and close out that are aligned with International Council for Harmonisation Good Clinical Practice (ICH-GCP), NHMRC guidelines, the National Clinical Trials Governance Framework (NCTGF) and SCHN Research Governance requirements.
SOPs are reviewed regularly and are version-controlled in a centralised repository.
SCHN clinical trials are governed by the relevant Research Ethics, Governance, Data Privacy, Security, Risk Management and Clinical Policies, ensuring compliance with NSW Health and SCHN standards.